MedTrace Logo

Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals

NCT00365235 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 998

Last updated 2012-01-12

No results posted yet for this study

Summary

Familial combined hyperlipidemia (FCHL) is an inherited disorder characterized by elevated levels of cholesterol and triglycerides; it often occurs in Mexican individuals with coronary heart disease (CHD). The purpose of this study is to identify the specific genes that predispose Mexican individuals to FCHL.

Conditions

  • Hyperlipidemia, Familial Combined
  • Coronary Disease

Sponsors & Collaborators

Principal Investigators

  • Paivi E. Pajukanta, MD, PhD · David Geffen School of Medicine at UCLA, Department of Human Genetics

Eligibility

Min Age
10 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00365235 on ClinicalTrials.gov